Alfresa Holdings Corporation (TYO:2784)

Japan flag Japan · Delayed Price · Currency is JPY
2,591.50
-57.50 (-2.17%)
Mar 3, 2026, 3:30 PM JST
29.96%
Market Cap 470.92B
Revenue (ttm) 3.06T
Net Income (ttm) 33.64B
Shares Out 181.72M
EPS (ttm) 184.82
PE Ratio 14.02
Forward PE 14.97
Dividend 68.00 (2.57%)
Ex-Dividend Date Mar 30, 2026
Volume 351,600
Average Volume 327,500
Open 2,628.50
Previous Close 2,649.00
Day's Range 2,590.00 - 2,634.00
52-Week Range 1,897.00 - 2,685.50
Beta -0.27
RSI 58.39
Earnings Date Feb 10, 2026

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract dis... [Read more]

Sector Healthcare
Founded 2003
Employees 12,452
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 2784
Full Company Profile

Financial Performance

In fiscal year 2025, Alfresa Holdings's revenue was 2.96 trillion, an increase of 3.59% compared to the previous year's 2.86 trillion. Earnings were 27.39 billion, a decrease of -7.34%.

Financial Statements

News

There is no news available yet.